Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Psychosis and Antipsychotic Drugs: Overview

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...

Treatment Strategies for Psychological Disorders

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...

Community Based Intervention

Community Based Intervention

Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Undermeasured and underused: Could a pharmacy accountability measure increase the use of clozapine?

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Same author

Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression.

The American journal of drug and alcohol abuse·2025

Same author

Assessing suboxone access in community pharmacies: Secret shopper model.

Exploratory research in clinical and social pharmacy·2023

Same author

Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.

Substance abuse·2023

Same author

Opioid Use Disorder Curricular Content in US-Based Doctor of Pharmacy Programs.

American journal of pharmaceutical education·2023

Same author

Inpatient prescribing patterns of long-acting injectables and their oral or short-acting injectable equivalent formulations.

Frontiers in pharmacology·2023

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

The Tail Suspension Test

The Tail Suspension Test

Published on: January 28, 2012

Psychiatric pharmacy residency training.

Steven C Stoner¹, Carol A Ott, Bethany A Dipaula

¹University of Missouri, Kansas City School of Pharmacy, Kansas City, Missouri 64108, USA. stoners@umkc.edu

American Journal of Pharmaceutical Education

|February 9, 2011

Summary

This summary is machine-generated.

Psychiatric pharmacists enhance mental healthcare. The College of Psychiatric and Neurologic Pharmacists (CPNP) advocates for accredited residency programs to ensure high-quality specialized care for psychiatric conditions.

Keywords:

American Society of Health-System Pharmacists (ASHP)postgraduate education psychiatric pharmacy residency

Related Experiment Videos

Last Updated: Jun 4, 2026

The Tail Suspension Test

The Tail Suspension Test

Published on: January 28, 2012

Area of Science:

Psychiatric Pharmacy
Mental Healthcare

Background:

The role of psychiatric pharmacists has evolved significantly since the 1970s.
These professionals focus on improving the health and safety of individuals with psychiatric conditions.

Purpose of the Study:

To advocate for the accreditation of Psychiatric Pharmacy residency programs by the American Society of Health-System Pharmacy (ASHP).
To support the advancement of psychiatric pharmacy as a recognized specialty.

Main Methods:

The College of Psychiatric and Neurologic Pharmacists (CPNP) has taken a position on residency program accreditation.
This position is based on establishing minimum training standards and ensuring quality of care through board certification.

Main Results:

Accreditation of residency programs by ASHP is recommended.
Board certification processes are crucial for maintaining high standards in psychiatric pharmacy.

Conclusions:

Accredited Psychiatric Pharmacy residency programs are essential for professional advancement.
Ensuring standardized training and certification will elevate the quality of care provided by psychiatric pharmacists.